Initial FDA Approval and Starting Dosage (2007)
Sapropterin dihydrochloride (Kuvan), approved by the FDA in December 2007 for phenylketonuria (PKU) in patients 4 years and older responsive to the drug, started with a recommended dosage of 10 mg/kg once daily. Patients began with a 1-month trial at this dose, with responders continuing indefinitely.[1]
Dosage Adjustments for Age and Weight (2008–2010)
By 2008, labeling clarified dosing by body weight bands for practicality:
- 100–20,000 mg/day total, rounded to nearest 100 mg increment.
- Tablets (100 mg) or powder (100 mg per packet).
In 2009, FDA expanded approval to children 0–4 years responsive to sapropterin, maintaining the 10 mg/kg daily dose but with pediatric-specific titration guidance.[1][2]
Expanded Indications and Flexible Dosing (2013–2018)
2013 approval for tetrahydrobiopterin (BH4)-responsive hyperphenylalaninemia (HPA) kept the 10 mg/kg core dose but allowed up to 20 mg/kg/day if response inadequate after 1 month at 10 mg/kg.[1]
2018 approval of dissolving tablets (Kvyn) introduced the same 10–20 mg/kg range, with once-daily or divided dosing (three times daily) for better tolerance in some patients.[3]
Recent Updates and Generic Entry (2020s)
No core dosage changes since 2018, but 2022 generic approvals (e.g., by Aurobindo) adopted identical 10–20 mg/kg labeling. Prescribing now emphasizes starting at 10 mg/kg, escalating only if phenylalanine levels drop insufficiently, with monitoring every 1–2 weeks initially.[1][4]
Maximum remains 20 mg/kg/day; higher doses lack safety data.
Why Dosage Range Expanded
Early trials (e.g., Phase 3 PKU-004) showed ~50% responders at 10 mg/kg, but 20–30% needed 20 mg/kg for optimal phenylalanine control (<360 μmol/L). This led to the flexible range, balancing efficacy and GI side effects (more common >10 mg/kg).[2][5]
How Dosing Is Calculated Today
| Weight (kg) | 10 mg/kg Dose | 20 mg/kg Dose |
|-------------|---------------|---------------|
| 10 | 100 mg | 200 mg |
| 20 | 200 mg | 400 mg |
| 30 | 300 mg | 600 mg |
| 40+ | 400+ mg | 800+ mg |
Administer orally, with food to reduce nausea; powder mixes in 2–8 oz water/liquid.[1]
[1]: FDA Label for Kuvan (2007–current)
[2]: PKU Trial Data (NEJM 2007)
[3]: FDA Kvyn Approval (2018)
[4]: Generic Sapropterin Label (2022)
[5]: BioMarin Dosing Rationale (2013)